🔗 Permalink

Inventor profile of:

Mitchell Ho

City:

Urbana, Maryland

Country:

United States

Published Applications:

Last publication date:

2026-03-12

Top Assignees for applications by Mitchell Ho

The entities that hold a legal rights for patent applications filed by inventor Ho Mitchell:

The USA, as represented by the Secretary, Department of Health and Human Services 18 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 12 Bethesda, MD United States
The United States of America,as represented by the Secretary,Department of Health and Human Services 6 Bethesda, MD United States
The United States of America, as represented by the Secretary, Department of Health and Human Services 6 Washington, DC United States
The United States of America, as represented by the Secretary, Department of Health and Human Servic 1 Bethesda, MD United States
The United States of America,as represented by the Secretary,Department of Health and Human Service 1 Bethesda, MD United States
EUREKA THERAPEUTICS, INC. 1 Emeryville, CA United States
The U.S.A., as represented by the Secretary, Department of Health and Human Services 1 Betheda, MD United States

Recent patent applications by Ho Mitchell

Mitchell Ho from Urbana, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2026-03-12

US20260070960A1

Chemistry; metallurgy

SINGLE DOMAIN ANTIBODIES TARGETING HPV E6/E7 ONCOGENIC PEPTIDE/MHC COMPLEXES

#2 | 2025-09-11

US20250281538A1

Human necessities

COMPOSITIONS TARGETING GPC2 AND GPC3 AND THEIR USE FOR TREATING SOLID TUMORS

#3 | 2025-05-08

US20250144214A1

Human necessities

CD28 HINGE AND TRANSMEMBRANE CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GPC2 AND USE THEREOF

#4 | 2025-01-16

US20250018040A1

Human necessities

ANTI-MESOTHELIN POLYPEPTIDES, PROTEINS, AND CHIMERIC ANTIGEN RECEPTORS

#5 | 2025-01-16

US20250017962A1

Human necessities

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-3 (GPC3) AND USE THEREOF

#6 | 2024-12-19

US20240417446A1

Chemistry; metallurgy

SINGLE DOMAIN ANTIBODIES TARGETING THE S2 SUBUNIT OF SARS-COV-2 SPIKE PROTEIN

#7 | 2024-09-12

US20240301084A1

Chemistry; metallurgy

HIGH AFFINITY MONOCLONAL ANTIBODIES TARGETING GLYPICAN-2 AND USES THEREOF

#8 | 2024-08-15

US20240270851A1

Chemistry; metallurgy

CROSS SPECIES SINGLE DOMAIN ANTIBODIES TARGETING PD-L1 FOR TREATING SOLID TUMORS

#9 | 2024-07-11

US20240228657A9

Chemistry; metallurgy

IMMUNOTOXINS WITH ALBUMIN BINDING DOMAIN

#10 | 2024-07-04

US20240218055A1

Chemistry; metallurgy

LASSA VIRUS-SPECIFIC NANOBODIES AND METHODS OF THEIR USE

#11 | 2024-04-25

US20240132619A1

Chemistry; metallurgy

Immunotoxins with albumin binding domain

#12 | 2023-12-21

US20230406953A1

Chemistry; metallurgy

CHIMERIC ANTIGEN RECEPTORS TARGETING TUMOR ANTIGENS

#13 | 2023-12-07

US20230391852A1

Chemistry; metallurgy

SINGLE DOMAIN ANTIBODIES TARGETING SARS CORONAVIRUS SPIKE PROTEIN AND USES THEREOF

#14 | 2023-10-26

US20230340146A1

Chemistry; metallurgy

IGG4 HINGE-CONTAINING CHIMERIC ANTIGEN RECEPTORS TARGETING GLYPICAN-1 (GPC1) FOR TREATING SOLID TUMORS

#15 | 2022-12-01

US20220380471A1

Chemistry; metallurgy

HIGH AFFINITY NANOBODIES TARGETING B7-H3 (CD276) FOR TREATING MULTIPLE SOLID TUMORS

#16 | 2022-03-31

US20220098323A1

Chemistry; metallurgy

High affinity monoclonal antibodies targeting glypican-1 and methods of use

#17 | 2022-03-03

US20220064324A1

Chemistry; metallurgy

Cross species single domain antibodies targeting mesothelin for treating solid tumors

#18 | 2021-12-02

US20210371542A1

Chemistry; metallurgy

Chimeric antigen receptors targeting glypican-3 or mesothelin

#19 | 2021-09-23

US20210292428A1

Chemistry; metallurgy

High affinity monoclonal antibodies targeting glypican-2 and uses thereof

#20 | 2020-08-06

US20200247901A1

Chemistry; metallurgy

Anti-mesothelin polypeptides and proteins

#21 | 2020-07-16

US20200223937A1

Chemistry; metallurgy

Immunotoxins with albumin binding domain

#22 | 2020-07-09

US20200216558A1

Chemistry; metallurgy

Monoclonal antibodies targeting glypican-2 (GPC2) and use thereof

#23 | 2018-05-17

US20180134800A1

Chemistry; metallurgy

Human monoclonal antibodies specific for glypican-3 and use thereof

#24 | 2016-08-11

US20160229919A1

Chemistry; metallurgy

Mesothelin domain-specific monoclonal antibodies and use thereof

#25 | 2016-07-21

US20160208015A1

Chemistry; metallurgy

Human monoclonal antibodies specific for glypican-3 and use thereof

#26 | 2015-12-24

US20150368340A1

Chemistry; metallurgy

Human monoclonal antibodies specific for glypican-3 and use thereof

#27 | 2015-10-01

US20150274836A1

Chemistry; metallurgy

Mesothelin antibodies and methods for eliciting potent antitumor activity

#28 | 2015-09-10

US20150252118A1

Chemistry; metallurgy

Mesothelin domain-specific monoclonal antibodies and use thereof

#29 | 2015-05-28

US20150147330A1

Chemistry; metallurgy

High-affinity monoclonal antibodies to glypican-3 and use thereof

#30 | 2014-02-13

US20140044714A1

Chemistry; metallurgy

Human monoclonal antibodies specific for glypican-3 and use thereof

InventorID:

649851 ⎘